ANDA 204649, held by Quagen. Acetaminophen; Butalbital; Caffeine; Codeine Phosphate.
As of Nov 16, 2026, ANDA 204649 (Butalbital, Acetaminophen, Caffeine And Codeine Phosphate), held by Quagen, was first approved by FDA on Jul 8, 2020, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 8, 2020 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butalbital, Acetaminophen, Caffeine And Codeine Phosphate325MG;50MG;40MG;30MG ยท capsule;oral | Acetaminophen; Butalbital; Caffeine; Codeine Phosphate | Discontinued |
| Jun 18, 2026 | Supplement 8REMS | Approved | None posted |
| Oct 31, 2024 | Supplement 4REMS | Approved | None posted |
| Jul 8, 2020 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters